Brief: Mesoblast Says James M. O’Brien Appointed Chief Financial Officer
17/11/2025 08:00
Nov 17 (Reuters) - Mesoblast Ltd MSB.AX: JAMES M. O’BRIEN APPOINTED CHIEF FINANCIAL OFFICER AT MESOBLAST Source text: ID:nGNX4fJbQm Further company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil